Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

18 June 2002

Apoptosis and pH of blasts in acute childhood leukemia.

Anna Stelmaszczyk-Emmel, Iwona Malinowska, Maria Wasik, Roma Rokicka-Milewska

Med Sci Monit 2002; 8(6): CR441-447 :: ID: 420810

Abstract

BACKGROUND: The purpose of our study was to determine whether spontaneousand post-initial therapy apoptosis indexes (AI) and the intracellular pH of blasts have prognostic valuein the treatment of children with acute leukemia.MATERIAL/METHODS: Blasts from 38 children with acuteleukemia (31 with ALL and 7 with AML) were tested for apoptotic index (Annexin V) and intracellular pH(SNARF). Of the ALL patients, 9 were low risk, 7 medium risk, and 15 high risk. Among the AML patients,1 was low risk and 6 were high risk. Follow-up ranged from 6 to 120 weeks (median 60 weeks).RESULTS:The mean spontaneous AI was 19 +/-16%. The pH of leukemic blasts before treatment varied between 6.6and 7.9 (mean 7.2 +/- 0.5). For patients < 10 years old, the markers for good prognosis were a WBC countbelow 50 x 10(3)/microml, good response to prednisone therapy at day 8, and remission at or before day33. Univariate analysis showed that pH < 7 had favorable prognostic significance. Overall, the probabilityof EFS for patients with pH < 7 was 1.0, as opposed to 0.49 for those with pH > 7 (p=0.049, n=36). Theprobability of EFS for patients with AI below the median was not significantly different from those withAI above the median (0.4 vs 1.0, NS).CONCLUSIONS: The assessment of intracellular pH in blasts may bean important prognosticator for ALL patients. Children with low spontaneous AI or high pH of leukemicblasts appear to have an unfavorable prognosis.

Keywords: Child, Child, Preschool, Hydrogen-Ion Concentration, Leukemia, Lymphocytic, Acute, L1, Leukemia, Myelocytic, Acute, Research Support, Non-U.S. Gov

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750